JP2023508731A5 - - Google Patents

Info

Publication number
JP2023508731A5
JP2023508731A5 JP2022540595A JP2022540595A JP2023508731A5 JP 2023508731 A5 JP2023508731 A5 JP 2023508731A5 JP 2022540595 A JP2022540595 A JP 2022540595A JP 2022540595 A JP2022540595 A JP 2022540595A JP 2023508731 A5 JP2023508731 A5 JP 2023508731A5
Authority
JP
Japan
Prior art keywords
sequence
seq
rgn
sequence identity
target dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022540595A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023508731A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/067138 external-priority patent/WO2021138247A1/en
Publication of JP2023508731A publication Critical patent/JP2023508731A/ja
Publication of JP2023508731A5 publication Critical patent/JP2023508731A5/ja
Pending legal-status Critical Current

Links

JP2022540595A 2019-12-30 2020-12-28 Rna誘導ヌクレアーゼ、その活性断片および多様体、ならびに使用方法 Pending JP2023508731A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962955014P 2019-12-30 2019-12-30
US62/955,014 2019-12-30
US202063058169P 2020-07-29 2020-07-29
US63/058,169 2020-07-29
PCT/US2020/067138 WO2021138247A1 (en) 2019-12-30 2020-12-28 Rna-guided nucleases and active fragments and variants thereof and methods of use

Publications (2)

Publication Number Publication Date
JP2023508731A JP2023508731A (ja) 2023-03-03
JP2023508731A5 true JP2023508731A5 (https=) 2024-01-09

Family

ID=74285554

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022540595A Pending JP2023508731A (ja) 2019-12-30 2020-12-28 Rna誘導ヌクレアーゼ、その活性断片および多様体、ならびに使用方法

Country Status (8)

Country Link
US (1) US20230203463A1 (https=)
EP (1) EP4085133A1 (https=)
JP (1) JP2023508731A (https=)
CN (1) CN115190912A (https=)
AU (1) AU2020417760A1 (https=)
CA (1) CA3163285A1 (https=)
TW (1) TW202134439A (https=)
WO (1) WO2021138247A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015330699B2 (en) 2014-10-10 2021-12-02 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
US20240247242A1 (en) 2020-07-15 2024-07-25 LifeEDIT Therapeutics, Inc. Uracil stabilizing proteins and active fragments and variants thereof and methods of use
US12171813B2 (en) 2021-02-05 2024-12-24 Christiana Care Gene Editing Institute, Inc. Methods of and compositions for reducing gene expression and/or activity
EP4453191A1 (en) 2021-12-23 2024-10-30 Bayer Aktiengesellschaft Novel small type v rna programmable endonuclease systems
KR20250126155A (ko) 2022-11-04 2025-08-22 라이프 에디트 테라퓨틱스, 인크. 내부 삽입 부위를 갖는 진화된 아데닌 데아미나제 및 rna-가이드 뉴클레아제 융합 단백질 및 사용 방법
WO2024178397A2 (en) 2023-02-24 2024-08-29 Elevatebio Technologies, Inc. Modified immune effector cells and methods of use
WO2024213138A1 (en) * 2023-04-12 2024-10-17 Huidagene Therapeutics Co., Ltd. Guide nucleic acids targeting vegfa and uses thereof
WO2025003358A2 (en) * 2023-06-29 2025-01-02 UCB Biopharma SRL Novel nucleic acid targeting systems comprising rna-guided nucleases
WO2026003754A1 (en) 2024-06-25 2026-01-02 Life Edit Therapeutics, Inc. Novel reverse transcriptases and uses thereof

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US699A (en) 1838-04-21 stone
US9840A (en) 1853-07-12 Improvement in tanning
US4217344A (en) 1976-06-23 1980-08-12 L'oreal Compositions containing aqueous dispersions of lipid spheres
US4196265A (en) 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4186183A (en) 1978-03-29 1980-01-29 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in chemotherapy of leishmaniasis
US4261975A (en) 1979-09-19 1981-04-14 Merck & Co., Inc. Viral liposome particle
US4485054A (en) 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US5380831A (en) 1986-04-04 1995-01-10 Mycogen Plant Science, Inc. Synthetic insecticidal crystal protein gene
US5049386A (en) 1985-01-07 1991-09-17 Syntex (U.S.A.) Inc. N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4946787A (en) 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5569597A (en) 1985-05-13 1996-10-29 Ciba Geigy Corp. Methods of inserting viral DNA into plant material
US4774085A (en) 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators
US4853331A (en) 1985-08-16 1989-08-01 Mycogen Corporation Cloning and expression of Bacillus thuringiensis toxin gene toxic to beetles of the order Coleoptera
US5268463A (en) 1986-11-11 1993-12-07 Jefferson Richard A Plant promoter α-glucuronidase gene construct
US5608142A (en) 1986-12-03 1997-03-04 Agracetus, Inc. Insecticidal cotton plants
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5039523A (en) 1988-10-27 1991-08-13 Mycogen Corporation Novel Bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
EP0388186A1 (en) 1989-03-17 1990-09-19 E.I. Du Pont De Nemours And Company External regulation of gene expression
ATE225853T1 (de) 1990-04-12 2002-10-15 Syngenta Participations Ag Gewebe-spezifische promotoren
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
WO1991017424A1 (en) 1990-05-03 1991-11-14 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
US5498830A (en) 1990-06-18 1996-03-12 Monsanto Company Decreased oil content in plant seeds
CA2051562C (en) 1990-10-12 2003-12-02 Jewel M. Payne Bacillus thuringiensis isolates active against dipteran pests
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5399680A (en) 1991-05-22 1995-03-21 The Salk Institute For Biological Studies Rice chitinase promoter
US5604121A (en) 1991-08-27 1997-02-18 Agricultural Genetics Company Limited Proteins with insecticidal properties against homopteran insects and their use in plant protection
TW261517B (https=) 1991-11-29 1995-11-01 Mitsubishi Shozi Kk
US5587308A (en) 1992-06-02 1996-12-24 The United States Of America As Represented By The Department Of Health & Human Services Modified adeno-associated virus vector capable of expression from a novel promoter
US5789156A (en) 1993-06-14 1998-08-04 Basf Ag Tetracycline-regulated transcriptional inhibitors
US5814618A (en) 1993-06-14 1998-09-29 Basf Aktiengesellschaft Methods for regulating gene expression
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5608144A (en) 1994-08-12 1997-03-04 Dna Plant Technology Corp. Plant group 2 promoters and uses thereof
US5659026A (en) 1995-03-24 1997-08-19 Pioneer Hi-Bred International ALS3 promoter
US6072050A (en) 1996-06-11 2000-06-06 Pioneer Hi-Bred International, Inc. Synthetic promoters
AR014072A1 (es) 1998-02-26 2001-01-31 Pioneer Hi Bred Int Molecula de acido nucleico aislada que tiene una secuencia nucleotidica para un promotor que es capaz de iniciar una transcripcion constitutiva en unacelula de planta, construccion adn, vector, celula huesped, metodo para expresar en forma constitutiva una secuencia nucleotidica heteroloca en una
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6555655B1 (en) 1999-05-04 2003-04-29 Monsanto Technology, Llc Coleopteran-toxic polypeptide compositions and insect-resistant transgenic plants
US6593293B1 (en) 1999-09-15 2003-07-15 Monsanto Technology, Llc Lepidopteran-active Bacillus thuringiensis δ-endotoxin compositions and methods of use
US20050183161A1 (en) 2003-10-14 2005-08-18 Athenix Corporation AXMI-010, a delta-endotoxin gene and methods for its use
WO2005066202A2 (en) 2003-12-22 2005-07-21 E.I. Du Pont De Nemours And Company Bacillus cry9 family members
AU2007260716B2 (en) 2006-06-14 2013-05-02 BASF Agricultural Solutions Seed US LLC Axmi-031, axmi-039, axmi-040 and axmi-049, a family of delta-endotoxin genes and methods for their use
US8383604B2 (en) 2008-09-15 2013-02-26 Children's Medical Center Corporation Modulation of BCL11A for treatment of hemoglobinopathies
ES2609332T3 (es) 2009-07-02 2017-04-19 Athenix Corporation Gen pesticida AXMI-205 y métodos para su uso
WO2011084324A2 (en) 2009-12-21 2011-07-14 Pioneer Hi-Bred International, Inc. Novel bacillus thuringiensis gene with lepidopteran activity
WO2012024200A2 (en) 2010-08-19 2012-02-23 Pioneer Hi-Bred International, Inc. Novel bacillus thuringiensis gene with lepidopteran activity
US9405700B2 (en) 2010-11-04 2016-08-02 Sonics, Inc. Methods and apparatus for virtualization in an integrated circuit
EP3196301B1 (en) 2012-07-11 2018-10-17 Sangamo Therapeutics, Inc. Methods and compositions for the treatment of monogenic diseases
US8697359B1 (en) * 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
EP3666892A1 (en) * 2013-07-10 2020-06-17 President and Fellows of Harvard College Orthogonal cas9 proteins for rna-guided gene regulation and editing
US20150165054A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting caspase-9 point mutations
EP3186375A4 (en) 2014-08-28 2019-03-13 North Carolina State University Novel CAS9 PROTEINS AND CHARACTERISTICS FOR DNA TARGETING AND GENOME EDITING
AU2016263026A1 (en) * 2015-05-15 2017-11-09 Pioneer Hi-Bred International, Inc. Guide RNA/Cas endonuclease systems
US9790490B2 (en) * 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
IL310721B2 (en) 2015-10-23 2025-11-01 Harvard College Nucleobase editors and uses thereof
AU2016380351B2 (en) * 2015-12-29 2023-04-06 Monsanto Technology Llc Novel CRISPR-associated transposases and uses thereof
CN110214183A (zh) 2016-08-03 2019-09-06 哈佛大学的校长及成员们 腺苷核碱基编辑器及其用途
BR112019006388A2 (pt) * 2016-09-30 2019-06-25 Univ California enzimas modificadoras de ácido nucleico guiadas por rna e métodos de uso das mesmas
WO2019046703A1 (en) * 2017-09-01 2019-03-07 Novozymes A/S METHODS OF ENHANCING GENOME EDITION IN FUNGI
US20200354419A1 (en) * 2017-11-03 2020-11-12 Hunterian Medicine Llc Compositions and methods of use thereof for the treatment of duchenne muscular dystrophy
US20210172008A1 (en) * 2018-04-04 2021-06-10 Lifeedit, Inc. Methods and compositions to identify novel crispr systems
PL3802807T3 (pl) * 2018-06-05 2025-03-31 Life Edit Therapeutics, Inc. Nukleazy kierowane rna i ich aktywne fragmenty oraz warianty i sposoby ich zastosowania
EP3830301B1 (en) 2018-08-01 2024-05-22 Mammoth Biosciences, Inc. Programmable nuclease compositions and methods of use thereof
WO2020139873A1 (en) 2018-12-24 2020-07-02 Virginia Polytechnic Institute And State University Tollip deficient neutrophils and uses thereof

Similar Documents

Publication Publication Date Title
JP2023508731A5 (https=)
US11802277B2 (en) Thermostable Cas9 nucleases
US20220033858A1 (en) Crispr oligoncleotides and gene editing
KR102382772B1 (ko) 화학적으로 변형된 가이드 rna를 사용하는 고 특이성 게놈 편집
Knapp et al. Transcription and processing of intervening sequences in yeast tRNA genes
JP7099724B2 (ja) 規定された配列および長さのdna1本鎖分子の拡大可能な生物工学的生成
CN103911376A (zh) CRISPR-Cas9靶向敲除乙肝病毒cccDNA及其特异性sgRNA
US20220298494A1 (en) Enzymes with ruvc domains
US12435323B2 (en) Enzymes with RUVC domains
EP4159853A1 (en) Genome editing system and method
US20220333129A1 (en) A nucleic acid delivery vector comprising a circular single stranded polynucleotide
CN116694603A (zh) 新型的Cas蛋白、Crispr-Cas系统及其在基因编辑领域中的用途
WO2017215517A1 (zh) 测序文库构建中5'和3'接头连接副产物的去除方法
US20220389418A1 (en) Rna-guided cas nucleases and uses thereof in diagnostics and therapy
CN118006584A (zh) CRISPR基因座完全缺失Cas1、Cas2和Cas4的可编程核酸酶及其应用
CN105602972B (zh) 基于CRISPR-Cas9体外改造腺病毒载体的方法
US12612657B2 (en) Extrachromosomal DNA labeling
US20240360477A1 (en) Systems and methods for transposing cargo nucleotide sequences
CN121737128A (zh) 一种提高环状rna稳定性的序列优化方法及应用和产品
CA3026372C (en) High specificity genome editing using chemically modified guide rnas
WO2024244000A1 (zh) 一种工程改造的sgRNA设计及制备方法
CA2989084C (en) Thermostable cas9 nucleases
Stansfield et al. Schaum's easy outlines
CA2957441C (en) Genome editing using campylobacter jejuni crispr/cas system-derived rgen
CN121717913A (zh) 一种腺嘌呤单碱基编辑系统及其应用